Posts Tagged ‘SynCardia’
A “bionic man” showcased in a Smithsonian Channel documentary and exhibit was designed as an artificial human, though it lacks several working organs. But it has a beating heart — the Total Artificial Heart, made by Tucson-based SynCardia Systems Inc.
SynCardia Total Artificial Heart Provides Bridge to Transplant for 25-Year-Old Southern California Man Whose Father Died of the Same Disease.
The Companion 2 (C2) Driver System is a CEO directed product championed by Rodger Ford during the time that he modernized the Total Artificial Heart.
Freedom® portable driver, the world’s first wearable power supply for the SynCardia temporary Total Artificial Heart, was named the 2013 Silver Winner amongst Assistive Devices in the Science/Medical category of the Edison Awards on April 25 in Chicago.
Under Jameson’s leadership, the C2 was rapidly developed to be the state-of-the-art driver of the SynCardia Total Artificial Heart used by SynCardia Certified Centers.
SynCardia announced today that the U.S. Food and Drug Administration (FDA) has approved two Humanitarian Use Device (HUD) designations for the new 50cc Total Artificial Heart to be used for destination therapy and pediatric bridge to transplant.
The Freedom Driver and its hospital companion, The Companion Driver were developed by Rodger Ford as CEO projects under his leadership of SynCardia from 2006 to 2011
Forbes Names SynCardia 69th among America’s Most Promising Companies.
SynCardia was 77th in 2011 and advanced to 69th in 2012.
The Freedom Driver and its hospital companion, The Companion Driver were developed by Rodger Ford as CEO projects under his leadership of SynCardia from 2006 to 2011. The driver family replaced the cumbersome and large 400 pound driver that was the size of a commercial washing machine. Now SynCardia patients can roam the hospital with the mobile Companion and when discharged enjoy the Freedom of a normal life. The Freedom Driver is about the same size as a portable oxygen system.
SynCardia Systems, Inc., manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced this month that the SynCardia temporary Total Artificial Heart has recently replaced left ventricular assist devices (LVADs) in seven patients suffering from end-stage heart failure; Two Patients Bridged to Transplant, Five Currently Waiting for a Matching Donor Heart.